Novus Therapeutics begins phase 1 trial of OP0201 in otitis media
Clinical trial news : Novus Therapeutics has initiated a phase 1 pharmacodynamics clinical trial of its lead candidate OP0201 for
Continue readingTag: Germany
Boehringer Ingelheim acquires oncolytic virus company ViraTherapeutics
German pharma company Boehringer Ingelheim has exercised its option to acquire 100% of Austria-based oncolytic virus company ViraTherapeutics for €210
Continue reading
Humira biosimilar Cyltezo meets objective in phase 3 plaque psoriasis trial
German pharma company Boehringer Ingelheim said that Cyltezo, a biosimilar to AbbVie psoriasis drug Humira, achieved clinical equivalence to the
Continue reading
Novartis’ heart failure drug Entresto can be initiated early in hospitalized patients
Swiss drugmaker Novartis unveiled new data on Entresto (sacubitril/valsartan) from a phase 4 study which confirms that the heart failure
Continue reading
BioNTech, Pfizer join forces to develop mRNA-based flu vaccines
BioNTech, a German biotechnology company, has joined forces with US pharma giant Pfizer to develop mRNA-based flu vaccines as part
Continue reading
Dutch pharma company Norgine opens new offices in Germany
Dutch pharma company Norgine has opened new offices in its largest product sales market – Germany at Wettenberg as part
Continue reading
Novartis to in-license atopic dermatitis drug MOR106 from MorphoSys, Galapagos
Novartis has agreed to acquire the exclusive global development and marketing rights of atopic dermatitis drug MOR106 from MorphoSys and
Continue reading
Vyriad, Merck to launch phase 1 study of immuno oncology drugs Voyager-V1 and avelumab
Vyriad, a US biotech company, has entered into a collaboration with Germany-based Merck to launch a phase 1 trial of
Continue reading
